Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations The drug, Aduhelm, brought in $300,000 in revenue in its [...] By digitalstudios|2021-10-20T20:06:11+00:00October 20, 2021|3rd Party Pharmaceutical Industry News|Comments Off on Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations Read More
Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients The rejection of the new Alzheimer’s drug by the two [...] By digitalstudios|2021-07-15T03:11:54+00:00July 15, 2021|3rd Party Pharmaceutical Industry News|Comments Off on Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients Read More